312 related articles for article (PubMed ID: 27830156)
1. Administration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes Mellitus.
He L; Wang H; Gu C; He X; Zhao L; Tong X
J Diabetes Res; 2016; 2016():1081657. PubMed ID: 27830156
[TBL] [Abstract][Full Text] [Related]
2. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
[TBL] [Abstract][Full Text] [Related]
3. Effect of cilostazol in treating diabetes-associated microvascular complications.
Asal NJ; Wojciak KA
Endocrine; 2017 May; 56(2):240-244. PubMed ID: 28293857
[TBL] [Abstract][Full Text] [Related]
4. Effects of sarpogrelate on microvascular complications with type 2 diabetes.
Yoo H; Park I; Kim DJ; Lee S
Int J Clin Pharm; 2019 Apr; 41(2):563-573. PubMed ID: 30864083
[TBL] [Abstract][Full Text] [Related]
5. Stationary Treatment Compared with Individualized Chinese Medicine for Type 2 Diabetes Patients with Microvascular Complications: Study Protocol for a Randomized Controlled Trial.
Huo J; Liu LS; Jian WY; Zeng JP; Duan JG; Lu XJ; Yin S
Chin J Integr Med; 2018 Oct; 24(10):728-733. PubMed ID: 29915910
[TBL] [Abstract][Full Text] [Related]
6. [Experimental research progress in traditional Chinese medicine prevention and treatment of diabetic peripheral neuropathy based on autophagy].
Huang SS; Wang XR; Yuan JS; DU L
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(23):6315-6323. PubMed ID: 38211988
[TBL] [Abstract][Full Text] [Related]
7. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
Kaabi YA
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
[TBL] [Abstract][Full Text] [Related]
8. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
Chilelli NC; Burlina S; Lapolla A
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
[TBL] [Abstract][Full Text] [Related]
9. A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms.
Liu XJ; Hu XK; Yang H; Gui LM; Cai ZX; Qi MS; Dai CM
Am J Chin Med; 2022; 50(7):1739-1779. PubMed ID: 36222120
[TBL] [Abstract][Full Text] [Related]
10. AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants.
Shrikanth CB; Nandini CD
Phytomedicine; 2020 Jul; 73():152808. PubMed ID: 30935723
[TBL] [Abstract][Full Text] [Related]
11. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
Valencia WM; Florez H
BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078
[TBL] [Abstract][Full Text] [Related]
12. Relationship of serum vitamin D levels with diabetic microvascular complications in patients with type 2 diabetes mellitus.
Zhao WJ; Xia XY; Yin J
Chin Med J (Engl); 2021 Feb; 134(7):814-820. PubMed ID: 33538508
[TBL] [Abstract][Full Text] [Related]
13. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
Boel E; Selmer J; Flodgaard HJ; Jensen T
J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
[TBL] [Abstract][Full Text] [Related]
14. Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice.
O'Brien PD; Hinder LM; Parlee SD; Hayes JM; Backus C; Zhang H; Ma L; Sakowski SA; Brosius FC; Feldman EL
Diabetes Obes Metab; 2017 Oct; 19(10):1468-1472. PubMed ID: 28332276
[TBL] [Abstract][Full Text] [Related]
15. Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.
Guo X; Xing Y; Jin W
Front Endocrinol (Lausanne); 2023; 14():1183586. PubMed ID: 37152974
[TBL] [Abstract][Full Text] [Related]
16. A clinical study on treatment of vascular complications of diabetes with the sugar--reducing and pulse--invigorating capsule.
Lin L; Zhang H; Gao Q; Ma J
J Tradit Chin Med; 1994 Mar; 14(1):3-9. PubMed ID: 8196413
[TBL] [Abstract][Full Text] [Related]
17. Study on the TCM pathogenesis of angiopathic complications of type II diabetes.
Liang P; Cao K
J Tradit Chin Med; 2008 Jun; 28(2):156-60. PubMed ID: 18652126
[TBL] [Abstract][Full Text] [Related]
18. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?
Leiter LA
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S3-14. PubMed ID: 15953505
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
Tremolada G; Lattanzio R; Mazzolari G; Zerbini G
Am J Cardiovasc Drugs; 2007; 7(6):393-8. PubMed ID: 18076206
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants and Their Associations to Type 2 Diabetes Mellitus Complications in the United Arab Emirates.
ElHajj Chehadeh S; Sayed NS; Abdelsamad HS; Almahmeed W; Khandoker AH; Jelinek HF; Alsafar HS
Front Endocrinol (Lausanne); 2021; 12():751885. PubMed ID: 35069435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
